ANTA
Antalpha Platform Holding Company
Financial - Credit Services
Market Cap$231M
5Y Perf.-23.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
ANTA vs CORZ
Revenue, margins, valuation, and 5-year total return — side by side.
CORZ
Core Scientific, Inc.
Software - Infrastructure
Market Cap$7.06B
5Y Perf.+110.0%
ANTA vs CORZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ANTA | CORZ |
|---|---|---|
| Industry | Financial - Credit Services | Software - Infrastructure |
| Market Cap | $231M | $7.06B |
| Revenue (TTM) | $47M | $355M |
| Net Income (TTM) | $4M | $-1.22B |
| Gross Margin | 37.8% | 16.9% |
| Operating Margin | 6.7% | -26.3% |
| Forward P/E | 24.4x | 267.1x |
| Total Debt | $410M | $1.06B |
| Cash & Equiv. | $6M | $311M |
ANTA vs CORZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
ANTA
CORZ
| Stock | May 25 | May 26 | Return |
|---|---|---|---|
| Antalpha Platform H… (ANTA) | 100 | 76.8 | -23.2% |
| Core Scientific, In… (CORZ) | 100 | 210.0 | +110.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ANTA vs CORZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ANTA leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Core Scientific, Inc. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ANTA
Antalpha Platform Holding Company
The Banking Pick
ANTA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.63
- Rev growth 321.0%, EPS growth 165.5%
- Lower volatility, beta 1.63, current ratio 1.05x
Best for: income & stability and growth exposure
CORZ
Core Scientific, Inc.
The Long-Run Compounder
CORZ is the clearest fit if your priority is long-term compounding.
- 5.5% 10Y total return vs ANTA's -23.9%
- +151.2% vs ANTA's -23.9%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ANTA | 321.0% NII/revenue growth vs CORZ's -37.5% |
| Value | ANTA | Lower P/E (24.4x vs 267.1x) |
| Quality / Margins | ANTA | 9.3% margin vs CORZ's -342.9% |
| Stability / Safety | ANTA | Beta 1.63 vs CORZ's 2.50 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | CORZ | +151.2% vs ANTA's -23.9% |
| Efficiency (ROA) | ANTA | 0.2% ROA vs CORZ's -50.2% |
ANTA vs CORZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2024
ANTA vs CORZ — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLANTALAGGINGCORZ
CORZCore Scientific, Inc.
1leads
ANTAAntalpha Platform Hol…
3leads
6 Total Categories
CATEGORYLEADERvs CORZMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ANTA5/5
Valuation MetricsMultiples, price ratios, and targets
ANTA2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ANTA5/5
Total Returns1Y, 3Y, 5Y total returns with dividends
CORZ6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
ANTA leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CORZ is the larger business by revenue, generating $355M annually — 7.5x ANTA's $47M. ANTA is the more profitable business, keeping 9.3% of every revenue dollar as net income compared to CORZ's -3.4%.
| Metric | ANTAAntalpha Platform… | CORZCore Scientific, … |
|---|---|---|
| RevenueTrailing 12 months | $47M | $355M |
| EBITDAEarnings before interest/tax | $2M | -$47M |
| Net IncomeAfter-tax profit | $4M | -$1.2B |
| Free Cash FlowCash after capex | $829,499 | -$471M |
| Gross MarginGross profit ÷ Revenue | +37.8% | +16.9% |
| Operating MarginEBIT ÷ Revenue | +6.7% | -26.3% |
| Net MarginNet income ÷ Revenue | +9.3% | -3.4% |
| FCF MarginFCF ÷ Revenue | -25.0% | -132.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +44.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +24.3% | -185.5% |
ANTA leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
ANTA leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ANTAAntalpha Platform… | CORZCore Scientific, … |
|---|---|---|
| Market CapShares × price | $231M | $7.1B |
| Enterprise ValueMkt cap + debt − cash | $635M | $7.8B |
| Trailing P/EPrice ÷ TTM EPS | 51.26x | -25.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.35x | 267.14x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 158.25x | — |
| Price / SalesMarket cap ÷ Revenue | 4.86x | 22.12x |
| Price / BookPrice ÷ Book value/share | 4.85x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
ANTA leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
ANTA leads this category, winning 5 of 5 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), ANTA scores 7/9 vs CORZ's 4/9, reflecting strong financial health.
| Metric | ANTAAntalpha Platform… | CORZCore Scientific, … |
|---|---|---|
| ROE (TTM)Return on equity | +5.1% | — |
| ROA (TTM)Return on assets | +0.2% | -50.2% |
| ROICReturn on invested capital | +0.6% | — |
| ROCEReturn on capital employed | +1.0% | -9.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 8.84x | — |
| Net DebtTotal debt minus cash | $404M | $749M |
| Cash & Equiv.Liquid assets | $6M | $311M |
| Total DebtShort + long-term debt | $410M | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | — | 5.50x |
ANTA leads this category, winning 5 of 5 comparable metrics.
Total Returns (Dividends Reinvested)
CORZ leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CORZ five years ago would be worth $65,000 today (with dividends reinvested), compared to $7,609 for ANTA. Over the past 12 months, CORZ leads with a +151.2% total return vs ANTA's -23.9%. The 3-year compound annual growth rate (CAGR) favors CORZ at 86.6% vs ANTA's -8.7% — a key indicator of consistent wealth creation.
| Metric | ANTAAntalpha Platform… | CORZCore Scientific, … |
|---|---|---|
| YTD ReturnYear-to-date | +6.7% | +39.8% |
| 1-Year ReturnPast 12 months | -23.9% | +151.2% |
| 3-Year ReturnCumulative with dividends | -23.9% | +550.0% |
| 5-Year ReturnCumulative with dividends | -23.9% | +550.0% |
| 10-Year ReturnCumulative with dividends | -23.9% | +550.0% |
| CAGR (3Y)Annualised 3-year return | -8.7% | +86.6% |
CORZ leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — ANTA and CORZ each lead in 1 of 2 comparable metrics.
Risk & Volatility
ANTA is the less volatile stock with a 1.63 beta — it tends to amplify market swings less than CORZ's 2.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CORZ currently trades 89.4% from its 52-week high vs ANTA's 35.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ANTAAntalpha Platform… | CORZCore Scientific, … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.63x | 2.50x |
| 52-Week HighHighest price in past year | $27.72 | $25.01 |
| 52-Week LowLowest price in past year | $6.25 | $8.74 |
| % of 52W HighCurrent price vs 52-week peak | +35.1% | +89.4% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 78.4 |
| Avg Volume (50D)Average daily shares traded | 6K | 13.6M |
Evenly matched — ANTA and CORZ each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ANTA as "Buy" and CORZ as "Buy".
| Metric | ANTAAntalpha Platform… | CORZCore Scientific, … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $23.80 |
| # AnalystsCovering analysts | 1 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
ANTA leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CORZ leads in 1 (Total Returns). 1 tied.
Best OverallAntalpha Platform Holding C… (ANTA)Leads 3 of 6 categories
Loading custom metrics...
ANTA vs CORZ: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ANTA or CORZ a better buy right now?
For growth investors, Antalpha Platform Holding Company (ANTA) is the stronger pick with 321.
0% revenue growth year-over-year, versus -37. 5% for Core Scientific, Inc. (CORZ). Antalpha Platform Holding Company (ANTA) offers the better valuation at 51. 3x trailing P/E (24. 4x forward), making it the more compelling value choice. Analysts rate Antalpha Platform Holding Company (ANTA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ANTA or CORZ?
On forward P/E, Antalpha Platform Holding Company is actually cheaper at 24.
4x.
03Which is the better long-term investment — ANTA or CORZ?
Over the past 5 years, Core Scientific, Inc.
(CORZ) delivered a total return of +550. 0%, compared to -23. 9% for Antalpha Platform Holding Company (ANTA). Over 10 years, the gap is even starker: CORZ returned +550. 0% versus ANTA's -23. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ANTA or CORZ?
By beta (market sensitivity over 5 years), Antalpha Platform Holding Company (ANTA) is the lower-risk stock at 1.
63β versus Core Scientific, Inc. 's 2. 50β — meaning CORZ is approximately 54% more volatile than ANTA relative to the S&P 500.
05Which is growing faster — ANTA or CORZ?
By revenue growth (latest reported year), Antalpha Platform Holding Company (ANTA) is pulling ahead at 321.
0% versus -37. 5% for Core Scientific, Inc. (CORZ). On earnings-per-share growth, the picture is similar: Antalpha Platform Holding Company grew EPS 165. 5% year-over-year, compared to 82. 9% for Core Scientific, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ANTA or CORZ?
Antalpha Platform Holding Company (ANTA) is the more profitable company, earning 9.
3% net margin versus -90. 5% for Core Scientific, Inc. — meaning it keeps 9. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ANTA leads at 6. 7% versus -45. 4% for CORZ. At the gross margin level — before operating expenses — ANTA leads at 37. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ANTA or CORZ more undervalued right now?
On forward earnings alone, Antalpha Platform Holding Company (ANTA) trades at 24.
4x forward P/E versus 267. 1x for Core Scientific, Inc. — 242. 8x cheaper on a one-year earnings basis.
08Which pays a better dividend — ANTA or CORZ?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is ANTA or CORZ better for a retirement portfolio?
For long-horizon retirement investors, Core Scientific, Inc.
(CORZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+550. 0% 10Y return). Antalpha Platform Holding Company (ANTA) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CORZ: +550. 0%, ANTA: -23. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ANTA and CORZ?
These companies operate in different sectors (ANTA (Financial Services) and CORZ (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ANTA is a small-cap high-growth stock; CORZ is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(ANTA: 321.0% · CORZ: 44.9%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.